]. L. Sheffield and C. W. Welsch, Cholera-toxin-enhanced growth of human breast cancer cell linesin vitro andin vivo: Interaction with estrogen, International Journal of Cancer, vol.107, issue.4, pp.479-483, 1985.
DOI : 10.1002/ijc.2910360411

D. Chalbos, A. Philips, F. Galtier, and H. Rochefort, Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'- monophosphate in MCF7 cells, Endocrinology, vol.133, pp.571-576, 1993.

M. Tanani and C. D. Green, Interaction between estradiol and cAMP in the regulation of specific gene expression, Molecular and Cellular Endocrinology, vol.124, issue.1-2, pp.71-77, 1996.
DOI : 10.1016/S0303-7207(96)03930-5

]. S. Aronica and B. S. Katzenellenbogen, Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I, Mol. Endocrinol, vol.7, issue.5, pp.743-752, 1993.

]. H. Cho and B. S. Katzenellenbogen, Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators, Mol. Endocrinol, vol.77, issue.6, pp.441-452, 1993.

M. Tanani and C. D. Green, Two Separate Mechanisms for Ligand-Independent Activation of the Estrogen Receptor, Molecular Endocrinology, vol.11, issue.7, pp.928-937, 1997.
DOI : 10.1210/mend.11.7.9939

B. S. Fujimoto and . Katzenellenbogen, Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3',5'-monophosphate and ligands including antiestrogens, Mol. Endocrinol. Mol. Endocrinol, vol.8, issue.8, pp.296-304, 1994.

F. Pakdel and B. S. Katzenellenbogen, Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination, J. Biol. Chem, vol.267, pp.3429-3437, 1992.

R. M. Evans, The steroid and thyroid hormone receptor superfamily, Science, vol.240, issue.4854, pp.889-895, 1988.
DOI : 10.1126/science.3283939

P. S. Danielan, R. White, J. A. Lees, and M. G. Parker, Identification of a conserved region required for hormone-dependent transcriptional activation by steroid hormone receptors, EMBO J, vol.11, pp.1025-1033, 1991.

D. Metzger, S. Ali, J. M. Bornert, and P. Chambon, Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells, J. Biol. Chem, vol.270, pp.9535-9542, 1995.

C. K. Glass, D. W. Rose, and M. G. Rosenfeld, Nuclear receptor coactivators, Current Opinion in Cell Biology, vol.9, issue.2, pp.222-232, 1997.
DOI : 10.1016/S0955-0674(97)80066-X

G. Lazennec, T. R. Ediger, L. N. Petz, A. M. Nardulli, and B. S. Katzenellenbogen, Mechanistic Aspects of Estrogen Receptor Activation Probed with Constitutively Active Estrogen Receptors: Correlations with DNA and Coregulator Interactions and Receptor Conformational Changes, Molecular Endocrinology, vol.11, issue.9, pp.11-1375, 1997.
DOI : 10.1210/mend.11.9.9983

K. Haussler and . Ozato, Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription, Proc. Natl. Acad. Sci. USA 92, pp.1535-1539, 1995.

C. Brou, J. Wu, S. Ali, E. Scheer, C. Lang et al., by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor, Nucleic Acids Research, vol.21, issue.1, pp.5-12, 1993.
DOI : 10.1093/nar/21.1.5

G. Lazennec, L. Kern, Y. Valotaire, and G. Salbert, The nuclear orphan receptors COUP-TF and ARP-1 positively regulate the trout estrogen receptor gene through enhancing autoregulation., Molecular and Cellular Biology, vol.17, issue.9, pp.17-5053, 1997.
DOI : 10.1128/MCB.17.9.5053

Y. Ledrean, D. Liu, A. Wong, F. Xiong, and C. L. Hew, Steroidogenic factor 1 and estradiol receptor act in synergism to regulate the expression of the salmon gonadotropin ii-beta subunit gene, Mol. Endocrinol, pp.10-217, 1996.

D. M. Ignar-trowbridge, M. Pimentel, M. G. Parker, J. A. Mclachlan, and K. S. Korach, Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol, Endocrinology, vol.137, pp.1735-1744, 1996.

M. P. Gaub, M. Bellard, I. Scheuer, P. Chambon, and P. Sassone-corsi, Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex, Cell, vol.63, issue.6, pp.1267-1276, 1990.
DOI : 10.1016/0092-8674(90)90422-B

J. N. Miner and K. R. Yamamoto, The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element., Genes & Development, vol.6, issue.12b, pp.2491-2501, 1992.
DOI : 10.1101/gad.6.12b.2491

R. Schüle, M. Muller, C. Kaltschmidt, and R. Renkawitz, Many transcription factors interact synergistically with steroid receptors, Science, vol.242, issue.4884, pp.1418-1420, 1988.
DOI : 10.1126/science.3201230

G. Bunone, P. A. Briand, R. J. Miksicek, and D. Picard, Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation, EMBO J, vol.15, pp.2174-2183, 1996.

S. Kato, H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama et al., Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase, Science, vol.270, issue.5241, pp.1491-1494, 1995.
DOI : 10.1126/science.270.5241.1491

V. C. Jordan and C. S. Murphy, Endocrine Pharmacology of Antiestrogens as Antitumor Agents*, Endocrine Reviews, vol.11, issue.4, pp.11-578, 1990.
DOI : 10.1210/edrv-11-4-578

B. S. Katzenellenbogen, M. M. Montano, K. Ekena, M. E. Herman, and E. M. Mcinerney, Antiestrogens: Mechanisms of action and resistance in breast cancer, Breast Cancer Research and Treatment, vol.55, issue.Suppl2, pp.44-67, 1997.
DOI : 10.1023/A:1005835428423

R. Santen, A. Manni, H. Harvey, and C. Redmond, Endocrine Treatment of Breast Cancer in Women, Endocrine Reviews, vol.11, issue.2, pp.11-221, 1990.
DOI : 10.1210/edrv-11-2-221

P. , L. Goff, M. M. Montano, D. J. Schodin, and B. S. Katzenellenbogen, Phosphorylation of the human estrogen receptor, J. Biol. Chem, vol.269, pp.4458-4466, 1994.

S. M. Aronica, W. L. Kraus, and B. S. Katzenellenbogen, Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription., Proc. Natl
DOI : 10.1073/pnas.91.18.8517

M. Y. Farhat, Y. S. Abi, B. Dingaan, R. Vargas, and P. W. , Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism, J. Pharmacol. Exper. Therapeut, pp.276-652, 1996.

P. K. Dash, K. A. Karl, M. A. Colicos, R. Prywes, and E. R. , cAMP response element-binding protein is activated by Ca2+/calmodulin- as well as cAMP-dependent protein kinase., Proceedings of the National Academy of Sciences, vol.88, issue.11, pp.5061-5065, 1991.
DOI : 10.1073/pnas.88.11.5061

M. Sheng, M. A. Thompson, and M. E. Greenberg, CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases, Science, vol.252, issue.5011, pp.1427-1430, 1991.
DOI : 10.1126/science.1646483

D. Chakravarti, V. J. Lamorte, M. C. Nelson, T. Nakajima, I. G. Schulman et al., Role of CBP/P300 in nuclear receptor signalling, Nature, vol.383, issue.6595, pp.99-103, 1996.
DOI : 10.1038/383099a0

B. Hanstein, R. Eckner, J. Direnzo, S. Halachmi, H. Liu et al., p300 is a component of an estrogen receptor coactivator complex., Proc. Natl. Acad, p.300
DOI : 10.1073/pnas.93.21.11540

Y. Kamei, L. Xu, T. Heinzel, J. Torchia, R. Kurokawa et al., A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors, Cell, vol.85, issue.3, pp.403-414, 1996.
DOI : 10.1016/S0092-8674(00)81118-6

M. M. Montano, K. Ekena, K. D. Krueger, A. L. Keller, and B. S. Katzenellenbogen, Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens, Mol. Endocrinol, pp.10-230, 1996.
DOI : 10.1210/me.10.3.230

D. A. Mead, E. Szczesna-skorupa, and B. Kemper, Single-stranded DNA ???blue??? T7 promoter plasmids: a versatile tandem promoter system for cloning and protein engineering, "Protein Engineering, Design and Selection", vol.1, issue.1, pp.67-74, 1986.
DOI : 10.1093/protein/1.1.67

T. A. Kunkel, J. D. Roberts, and R. A. Zakour, [19] Rapid and efficient site-specific mutagenesis without phenotypic selection, Methods Enzymol, vol.154, pp.367-382, 1987.
DOI : 10.1016/0076-6879(87)54085-X

K. Ekena, K. E. Weis, J. A. Katzenellenbogen, and B. S. Katzenellenbogen, Identification of Amino Acids in the Hormone Binding Domain of the Human Estrogen Receptor Important in Estrogen Binding, Journal of Biological Chemistry, vol.271, issue.33, p.271, 1996.
DOI : 10.1074/jbc.271.33.20053

S. Andersson, D. N. Davis, H. Dahlback, H. Jornvall, and D. W. Russell, Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme, J. Biol. Chem, vol.264, pp.8222-8229, 1988.

J. C. Reese and B. S. Katzenellenbogen, Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands, J. Biol. Chem, pp.266-10880, 1991.

G. Lazennec, L. Kern, G. Salbert, D. Saligaut, and Y. Valotaire, Cooperation between the human estrogen receptor (ER) and MCF-7 cell-specific transcription factors elicits high activity of an estrogen-inducible enhancer from the trout ER gene promoter, Mol. Endocrinol, pp.10-1116, 1996.

R. R. Denton, N. J. Koszewski, and A. C. Notides, Estrogen receptor phosphorylation. Hormonal dependence and consequence on specific DNA binding, J. Biol. Chem, vol.267, pp.7263-7268, 1992.

Y. Zhou, J. J. Watters, and D. M. Dorsa, Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain, Endocrinology, vol.137, pp.2163-2166, 1996.

K. M. Walton, R. P. Rehfuss, J. C. Chrivia, J. E. Lochner, and R. H. Goodman, A dominant repressor of cyclic adenosine 3',5'-monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo, Mol. Endocrinol, vol.6, pp.647-655, 1992.

G. A. Gonzalez and M. R. Montminy, Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133, Cell, vol.59, issue.4, pp.675-680, 1989.
DOI : 10.1016/0092-8674(89)90013-5

K. K. Yamamoto, G. A. Gonzalez, P. Menzel, J. Rivier, and M. R. Montminy, Characterization of a bipartite activator domain in transcription factor CREB, Cell, vol.60, issue.4, pp.611-617, 1990.
DOI : 10.1016/0092-8674(90)90664-Z

T. E. Meyer and J. F. Habener, Cyclic adenosine 3',5'-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid- binding proteins, Endocrine Reviews, vol.14, issue.3, pp.14-269, 1993.
DOI : 10.1210/er.14.3.269

G. A. Gonzalez, P. Menzel, J. Leonard, W. H. Fischer, and M. R. Montminy, Characterization of motifs which are critical for activity of the cyclic AMP-responsive transcription factor CREB., Molecular and Cellular Biology, vol.11, issue.3, pp.11-1306, 1991.
DOI : 10.1128/MCB.11.3.1306

M. Horikoshi, T. Hai, Y. S. Lin, M. R. Green, and R. G. Roeder, Transcription factor ATF interacts with the TATA factor to facilitate establishment of a preinitiation complex, Cell, vol.54, issue.7, pp.1033-1042, 1988.
DOI : 10.1016/0092-8674(88)90118-3

T. Hai and T. Curran, Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity., Proceedings of the National Academy of Sciences, vol.88, issue.9, pp.3720-3724, 1991.
DOI : 10.1073/pnas.88.9.3720

D. L. Carlone and J. S. Richards, Functional interactions, phosphorylation, and levels of 3',5'- cyclic adenosine monophosphate-regulatory element binding protein and steroidogenic factor

C. L. Smith, S. A. Onate, M. J. Tsai, and B. W. Malley, CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription., Proc. Natl. Acad. Sci. U S A 93, pp.8884-8888, 1996.
DOI : 10.1073/pnas.93.17.8884

T. P. Yao, G. Ku, N. Zhou, R. Scully, and D. M. Livingston, The nuclear hormone receptor coactivator SRC-1 is a specific target of p300., Proceedings of the National Academy of Sciences, vol.93, issue.20, pp.10626-10631, 1996.
DOI : 10.1073/pnas.93.20.10626

T. Chi, P. Lieberman, K. Ellwood, and M. Carey, A general mechanism for transcriptional synergy by eukaryotic activators, Nature, vol.377, issue.6546, pp.254-257, 1995.
DOI : 10.1038/377254a0

E. M. Martini, R. Mcinerney, K. Delage-mourroux, J. A. Weis, and . Katzenellenbogen, Estrogen receptors: selective ligands, partners, and distinctive pharmacology, Rec. Prog. Hormone Res, pp.55-163, 2000.